MICHAELA BLEYL: Open Payments
NPI 1902527401 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 21 payments from 10 companies in 2025. Trend: 2023 $107 · 2024 $475 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $79 |
| PFIZER INC. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Boston Scientific Corporation | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| HEARTFLOW, INC. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: REPATHA, VYNDAQEL, JARDIANCE, LEQVIO, CAMZYOS, WATCHMAN FLX, PRALUENT, FFRct.
Industry payments across UT — which companies pay providers there.
